TScan is dedicated to changing lives by discovering new cancer targets and developing safe and effective T-cell therapies for patients.
TScan’s therapeutic approach is based on the central premise that we can learn from patients who are winning their fight against cancer in order to treat those who are not.
Founder of Sepracor
President and CEO of TScan Therapeutics
Managing General Partner with Pitango Venture Capital
CFO of Nodthera
Chief Development Officer at Ichnos Sciences
Partner at Baker Bros. Advisors LP